The summit specifically brings together scientists and business leaders from academia, biotech and pharma to help you tackle the critical challenges in targeting neurodegenerative disease and accelerating the development of cutting edge therapeutics.
Understand the novel mechanisms at the forefront of neurodegenerative disease pathogenesis and discover how to identify and validate clinically relevant biomarkers, improve the translatability of pre-clinical modelling systems andrevolutionise clinical trial design to maximize the chance of drug approval.
Understand the novel mechanisms at the forefront of neurodegenerative disease pathogenesis and discover how to identify and validate clinically relevant biomarkers, improve the translatability of pre-clinical modelling systems andrevolutionise clinical trial design to maximize the chance of drug approval.
